Skip to content
10-K

Annual Report

AMERICAN BIO MEDICA CORPORATION

0001654954-23-003260

← back to feed
Filed
Mar 21, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 21, 2023 48.1M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$768K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$673K
Cash And Equivalents FY 2022 · Dec 31, 2022 $34K
Cash And Equivalents FY 2022 · Dec 31, 2021 $115K
Stockholders Equity FY 2022 · Dec 31, 2022 −$2.34M
Stockholders Equity FY 2022 · Dec 31, 2021 −$944K
Stockholders Equity FY 2022 · Dec 31, 2020 −$1.26M
Current Liabilities FY 2022 · Dec 31, 2022 $3.6M
Current Liabilities FY 2022 · Dec 31, 2021 $2.82M
Total Liabilities FY 2022 · Dec 31, 2022 $3.61M
Total Liabilities FY 2022 · Dec 31, 2021 $2.83M
Current Assets FY 2022 · Dec 31, 2022 $769K
Current Assets restated FY 2022 · Dec 31, 2021 $1.31M
Total Assets FY 2022 · Dec 31, 2022 $1.27M
Total Assets FY 2022 · Dec 31, 2021 $1.88M
Sga Expense FY 2022 · Dec 31, 2022 $917K
Sga Expense FY 2022 · Dec 31, 2021 $1.34M
Rd Expense FY 2022 · Dec 31, 2022 $85K
Rd Expense FY 2022 · Dec 31, 2021 $85K
Net Income FY 2022 · Dec 31, 2022 −$1.41M
Net Income FY 2022 · Dec 31, 2021 −$463K
Operating Income FY 2022 · Dec 31, 2022 −$1.24M
Operating Income FY 2022 · Dec 31, 2021 −$1.18M
Gross Profit FY 2022 · Dec 31, 2022 −$103K
Gross Profit FY 2022 · Dec 31, 2021 $548K
Cost Of Revenue FY 2022 · Dec 31, 2022 $1.11M
Cost Of Revenue FY 2022 · Dec 31, 2021 $1.67M
Revenue FY 2022 · Dec 31, 2022 $913K
Revenue FY 2022 · Dec 31, 2021 $2.22M